Cargando…

Hepatitis C Virus Treatment Revolution: Eastern European Story

Hepatitis C can be cured and even eradicated by new “revolutionary” treatments. However, at present exorbitant prices, Eastern European countries cannot afford the new treatments, while in western rich and developed countries (e.g. Germany and France) they are already available. Concerted efforts of...

Descripción completa

Detalles Bibliográficos
Autores principales: Stanciu, Carol, Trifan, Anca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539731/
https://www.ncbi.nlm.nih.gov/pubmed/26300932
http://dx.doi.org/10.5812/hepatmon.28969v2
_version_ 1782386154122772480
author Stanciu, Carol
Trifan, Anca
author_facet Stanciu, Carol
Trifan, Anca
author_sort Stanciu, Carol
collection PubMed
description Hepatitis C can be cured and even eradicated by new “revolutionary” treatments. However, at present exorbitant prices, Eastern European countries cannot afford the new treatments, while in western rich and developed countries (e.g. Germany and France) they are already available. Concerted efforts of governments, public health officials, and the community at large, are needed to negotiate agreements with pharmaceuticals companies to make the new treatments accessible and affordable. When science has demonstrated that hepatitis C can be cured, it would be unforgivable if millions of infected patients from eastern parts of the continent were denied access to new treatment on grounds of high prices and financial constraints.
format Online
Article
Text
id pubmed-4539731
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Kowsar
record_format MEDLINE/PubMed
spelling pubmed-45397312015-08-21 Hepatitis C Virus Treatment Revolution: Eastern European Story Stanciu, Carol Trifan, Anca Hepat Mon Rapid Communication Hepatitis C can be cured and even eradicated by new “revolutionary” treatments. However, at present exorbitant prices, Eastern European countries cannot afford the new treatments, while in western rich and developed countries (e.g. Germany and France) they are already available. Concerted efforts of governments, public health officials, and the community at large, are needed to negotiate agreements with pharmaceuticals companies to make the new treatments accessible and affordable. When science has demonstrated that hepatitis C can be cured, it would be unforgivable if millions of infected patients from eastern parts of the continent were denied access to new treatment on grounds of high prices and financial constraints. Kowsar 2015-07-22 /pmc/articles/PMC4539731/ /pubmed/26300932 http://dx.doi.org/10.5812/hepatmon.28969v2 Text en Copyright © 2015, Kowsar Corp. http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
spellingShingle Rapid Communication
Stanciu, Carol
Trifan, Anca
Hepatitis C Virus Treatment Revolution: Eastern European Story
title Hepatitis C Virus Treatment Revolution: Eastern European Story
title_full Hepatitis C Virus Treatment Revolution: Eastern European Story
title_fullStr Hepatitis C Virus Treatment Revolution: Eastern European Story
title_full_unstemmed Hepatitis C Virus Treatment Revolution: Eastern European Story
title_short Hepatitis C Virus Treatment Revolution: Eastern European Story
title_sort hepatitis c virus treatment revolution: eastern european story
topic Rapid Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539731/
https://www.ncbi.nlm.nih.gov/pubmed/26300932
http://dx.doi.org/10.5812/hepatmon.28969v2
work_keys_str_mv AT stanciucarol hepatitiscvirustreatmentrevolutioneasterneuropeanstory
AT trifananca hepatitiscvirustreatmentrevolutioneasterneuropeanstory